The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

TV personality Jun Hyun-moo’s agency denied allegations Friday that Jun received illegal medical treatment after a clip from ...

Expert opinions have emerged stating that Park Na-rae is unlikely to face punishment regarding allegations that she received ...

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

Click here for more articles b. Following allegations that comedian Park Na-rae received illegal medical treatment from a ...

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

Park Na-Rae could possible escape any kind of punishment in her alleged involvement in the 'injection aunt' scandal. Ki Seung-Guk, president of the Korean Society of Preventive Medicine Specialists ...

I once turned back from visiting a nearby internal medicine clinic during lunchtime due to a cold. The waiting room was ...

Mario Lopez has been working out most of his life, but at the age of 52, it's starting to catch up to him. "I've been getting ...

FDA approves Johnson & Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...